KATHLEEN DAVIS: Open Payments
NPI 1881289262 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 9 payments from 6 companies in 2025. Trend: 2023 $205 · 2024 $55 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $136 |
| ABBVIE INC. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: DUPIXENT, RINVOQ, VOQUEZNA, OMVOH, SKYRIZI, ENTYVIO.
Industry payments across MO — which companies pay providers there.
